A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.
EP. 1: Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and Diabetic Macular Edema